Projects per year
Personal profile
Headline
PROFESSOR | Pharmacological Sciences
Biography
Fingerprint
Dive into the research topics where E. Premkumar Reddy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
ON012380: A Non-ATP Competitive Inhibitor of BCR-ABL for the Therapy of Imatinib-Resistant CMLs
1/01/05 → 31/12/05
Project: Research
-
CDK4: a master regulator of the cell cycle and its role in cancer
Baker, S. J., Poulikakos, P. I., Irie, H. Y., Parekh, S. & Reddy, E. P., 2022, In: Genes and Cancer. 13, p. 21-45 25 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Correction: critical interactions between TGF-β signaling/ELF, and E-cadherin/β-catenin mediated tumor suppression (Oncogene, (2006), 25, 13, (1871-1886), 10.1038/sj.onc.1209211)
Katuri, V., Tang, Y., Li, C., Jogunoori, W., Deng, C. X., Rashid, A., Sidawy, A. N., Evans, S., Reddy, E. P., Mishra, B. & Mishra, L., 6 May 2021, In: Oncogene. 40, 18, p. 3348-3349 2 p.Research output: Contribution to journal › Comment/debate
Open Access -
A Contaminant Impurity, Not Rigosertib, Is a Tubulin Binding Agent
Baker, S. J., Cosenza, S. C., Athuluri-Divakar, S., Reddy, M. V. R., Vasquez-Del Carpio, R., Jain, R., Aggarwal, A. K. & Reddy, E. P., 2 Jul 2020, In: Molecular Cell. 79, 1, p. 180-190.e4Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Rigosertib ameliorates the effects of oncogenic KRAS signaling in a murine model of myeloproliferative neoplasia
Baker, S. J., Cosenza, S. C., Reddy, MV. R. & Reddy, E. P., 1 Mar 2019, In: Oncotarget. 10, 20, p. 1932-1942 11 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import
Rodriguez-Bravo, V., Pippa, R., Song, W. M., Carceles-Cordon, M., Dominguez-Andres, A., Fujiwara, N., Woo, J., Koh, A. P., Ertel, A., Lokareddy, R. K., Cuesta-Dominguez, A., Kim, R. S., Rodriguez-Fernandez, I., Li, P., Gordon, R., Hirschfield, H., Prats, J. M., Reddy, E. P., Fatatis, A., Petrylak, D. P., & 9 others, 23 Aug 2018, In: Cell. 174, 5, p. 1200-1215.e20Research output: Contribution to journal › Article › peer-review
Open Access70 Scopus citations
Press / Media
-
CDK4: A master regulator of the cell cycle and its role in cancer
E. Premkumar Reddy, Poulikos Poulikakos, Stacey Baker & Samir Parekh
5/12/22
3 items of Media coverage
Press/Media
-
Master regulator of cell cycle and its role in cancer
E. Premkumar Reddy, Poulikos Poulikakos, Stacey Baker & Samir Parekh
3/12/22
1 item of Media coverage
Press/Media
-
Genes & Cancer | CDK4: a master regulator of the cell cycle and its role in cancer
E. Premkumar Reddy, Poulikos Poulikakos, Stacey Baker & Samir Parekh
2/12/22
2 items of Media coverage
Press/Media
-
-
Onconova Therapeutics : PHASE 1 CLINICAL TRIAL UPDATES FOR ORAL RIGOSERTIB & PD-1 INHIBITOR IN KRAS-MUTATED NSCLC - RAJWANTH VELUSWAMY, MD MSCR
22/09/21
1 item of Media coverage
Press/Media